4//SEC Filing
Khosla Rachna 4
Accession 0000318154-25-000082
CIK 0000318154other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 7:29 PM ET
Size
5.2 KB
Accession
0000318154-25-000082
Insider Transaction Report
Form 4
AMGEN INCAMGN
Khosla Rachna
SVP, Business Development
Transactions
- Sale
Common Stock
2025-11-12$336.24/sh−890$299,256→ 7,082 total
Footnotes (2)
- [F1]The price reported is an average price. The prices ranged from $336.2219 to $336.30 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- [F2]These shares include 93 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeother
Related Parties
1- filerCIK 0001881332
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 7:29 PM ET
- Size
- 5.2 KB